Enteric Neurons With Alpha Synuclein Pathology is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The enteric nervous system (ENS) is one of the earliest sites of α-synuclein pathology in Parkinson's disease, making enteric neurons critical for understanding disease progression and early detection.
Gastrointestinal dysfunction precedes motor symptoms in PD by years or decades. α-Synuclein (α-syn) pathology in enteric neurons is now recognized as a potential early biomarker and window into disease pathogenesis.
- Myenteric plexus (Auerbach): Motor control
- Submucosal plexus (Meissner): Secretion, blood flow
- Neuron types: Sensory, motor, interneurons
- Cholinergic neurons: Excitatory motor neurons
- Nitrergic neurons: Inhibitory motor neurons
- Sensory neurons: Mechanosensitive, chemosensory
- Interneurons: Local circuits
- Early involvement: Appears before CNS
- Distribution: Throughout ENS
- Cell types: Primarily cholinergic neurons
- Progression: Likely spreads to brain
- Phosphorylated α-syn: Pathological form
- Oligomers: Toxic species
- Fibrils: Aggregate form
- Strain variations: Different conformations
- Constipation: Most common early symptom
- Delayed gastric emptying: Nausea, fullness
- Small intestinal bacterial overgrowth: GI complications
- Rectal biopsy: Detection of α-syn
- Colonic biopsies: Research applications
- Enema samples: Less invasive options
- Braak hypothesis: Gut to brain spread
- Vagal nerve: Proposed transmission route
- Retrograde transport: Via axons
- Template seeding: Pathological α-syn
- Neuronal type: Cholinergic vulnerability
- Environmental triggers: Pesticides, microbiome
- Genetic factors: Risk variants
- Motor dysfunction: Altered peristalsis
- Secretory changes: Impaired secretion
- Sensory alterations: Visceral hypersensitivity
- Oxidative stress: Dopamine oxidation
- Mitochondrial dysfunction: Complex I deficiency
- ER stress: Protein misfolding
- Neuroinflammation: Microglial activation
- Sensitive detection: Ultrasensitive assays
- Cell-specific markers: Improved targeting
- Longitudinal studies: Disease progression
- α-Synuclein reduction: siRNA approaches
- Prion-like spread blocking: Antibody therapies
- Gut-brain axis modulation: Microbiome interventions
The study of Enteric Neurons With Alpha Synuclein Pathology has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak H, et al. (2003). α-Synuclein in enteric nervous system. Neurobiol Aging.
- Shannon KM, et al. (2012). Enteric α-synuclein and GI dysfunction. Mov Disord.
- Lionnet A, et al. (2021). α-Synuclein in the ENS. Nat Rev Gastroenterol Hepatol.